<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1alpha expression.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1alpha expression." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791489/bin/12253_2008_9143_Fig1_HTML.jpg"/> </div> <div class="text-side"> <h1>Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1alpha expression.</h1> <p>Immunohistochemical analysis of Beclin-1 and HIF-1α in esophageal squamous cell carcinoma. a Positive Beclin-1 immunoreactivity in cytoplasm of normal squamous epithelial cells. b Negative Beclin-1 immunoreactivity in tumour cells. c Positive Beclin-1 immunoreactivity in cytoplasm and cytomembrane of tumour cells. d In normal squamous epithelial cells, HIF-1α immunoreactivity was not detected. e Weak HIF-1α immunoreactivity in cytoplasm of tumour cells. f Strong HIF-1α immunoreactivity in tumour cells. Original magnification: a, e and f, ×200; b and d, ×100; c, ×400</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/19130303/" target="_blank">19130303</a></p><p>Type: Premalignant/Malignant, Category: Keratinocytic</p>
</div> </div></div></body></html>